scPharmaceuticals (SCPH)

• Market cap: $129M
• 1 day: 0.78%
• 5 days: 27.86%
• 1 month: -14.33%
• 3 months: -21.65%
• 6 months: -41.46%
• Year to date: -28.01%
• 1 year: -41.86%
• 5 years: -71.38%
• 10 years: -81.77%
• Sector: Healthcare
• Industry: Biotechnology

About: scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

Employees: 96

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

687% more call options, than puts

Call options by funds: $614K | Put options by funds: $78K

131% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 16

5.02% more ownership

Funds ownership: 74.46% [Q3] → 79.49% (+5.02%) [Q4]

11% less funds holding

Funds holding: 95 [Q3] → 85 (-10) [Q4]

17% less capital invested

Capital invested by funds: $170M [Q3] → $141M (-$29M) [Q4]

35% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 26

50% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $12 367% upside
• Avg. target: $15 484% upside
• High target: $18 600% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Naz Rahman 8% 1-year accuracy 1 / 12 met price target	367% upside $12	Buy Maintained	20 Mar 2025
HC Wainwright & Co. Douglas Tsao 17% 1-year accuracy 29 / 171 met price target	600% upside $18	Buy Reiterated	20 Mar 2025